Diffuse large B-cell lymphoma
S Li, KH Young, LJ Medeiros - Pathology, 2018 - Elsevier
Diffuse large B cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma
worldwide, representing approximately 30–40% of all cases in different geographic regions …
worldwide, representing approximately 30–40% of all cases in different geographic regions …
Diagnosis of 'double hit'diffuse large B-cell lymphoma and B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma: when …
SH Swerdlow - Hematology 2014, the American Society of …, 2014 - ashpublications.org
Identification of large B-cell lymphomas that are “extra-aggressive” and may require therapy
other than that used for diffuse large B-cell lymphoma, not otherwise specified (DLBCL …
other than that used for diffuse large B-cell lymphoma, not otherwise specified (DLBCL …
Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
H Tilly, MG Da Silva, U Vitolo, A Jack… - Annals of …, 2015 - annalsofoncology.org
Diffuse large B-cell lymphoma (DLBCL) constitutes 30%–58% of non-Hodgkin's lymphoma
series. The crude incidence in Europe is 3.8/100 000/year [1]. The incidence increases with …
series. The crude incidence in Europe is 3.8/100 000/year [1]. The incidence increases with …
MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA/LYSA study
C Copie-Bergman, P Cuillière-Dartigues… - Blood, The Journal …, 2015 - ashpublications.org
Diffuse large B-cell lymphoma (DLBCL) with MYC rearrangement (MYC-R) carries an
unfavorable outcome. We explored the prognostic value of the MYC translocation partner …
unfavorable outcome. We explored the prognostic value of the MYC translocation partner …
[HTML][HTML] Prognostic factors for diffuse large B-cell lymphoma in the R (X) CHOP era
Background The introduction of rituximab (R) to conventional CHOP chemotherapy for newly
diagnosed diffuse large B-cell lymphoma (DLBCL) led to an unequivocal improvement in …
diagnosed diffuse large B-cell lymphoma (DLBCL) led to an unequivocal improvement in …
[HTML][HTML] Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma
SM Aukema, M Kreuz, CW Kohler, M Rosolowski… - …, 2014 - ncbi.nlm.nih.gov
Chromosomal translocations affecting the MYC oncogene are the biological hallmark of
Burkitt lymphomas but also occur in a subset of other mature B-cell lymphomas. If …
Burkitt lymphomas but also occur in a subset of other mature B-cell lymphomas. If …
Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas
RK Pillai, M Sathanoori, SB Van Oss… - The American journal …, 2013 - journals.lww.com
Double-hit (DH) lymphomas with MYC and either BCL2 (DH-BCL2/MYC) or BCL6 (DH-
BCL6/MYC) rearrangements are considered very aggressive, many of which are now …
BCL6/MYC) rearrangements are considered very aggressive, many of which are now …
Defining and treating high-grade B-cell lymphoma, NOS
High-grade B-cell lymphoma (HGBL), not otherwise specified (NOS), is a recently introduced
diagnostic category for aggressive B-cell lymphomas. It includes tumors with Burkitt-like or …
diagnostic category for aggressive B-cell lymphomas. It includes tumors with Burkitt-like or …
B‐cell lymphoma, unclassifiable, with features intermediate between diffuse large B‐cell lymphoma and burkitt lymphoma: study of 39 cases
B‐cell lymphoma, unclassifiable (B‐UCL), with features intermediate between diffuse large
B‐cell lymphoma and Burkitt lymphoma, is a poorly characterized entity. Therefore, we …
B‐cell lymphoma and Burkitt lymphoma, is a poorly characterized entity. Therefore, we …
Non‐Hodgkin's Lymphoma
AS Freedman, AS LaCasce - Holland‐Frei Cancer Medicine, 2016 - Wiley Online Library
Overview The malignant lymphomas are neoplastic transformations of cells that reside
predominantly within lymphoid tissues. Although Hodgkin and non‐Hodgkin lymphomas …
predominantly within lymphoid tissues. Although Hodgkin and non‐Hodgkin lymphomas …